INZY
Inozyme Pharma Inc Ordinary Shares
North American company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XNAS
-
Updated: -
Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies.
NASDAQ:INZY
US45790W1080
USD
Loading Comparison
Latest INZY News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News